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proteins in the speciﬁc DNA/protein complex were identiﬁed by
mass spectrometry. siRNAs speciﬁc for p130cas and Hsp90 were
transfected, alone or in combination, into L-OA chondrocytes,
and the cells were incubated in the absence or presence of IL-1β
(100 pg/ml). Total RNA was extracted and processed for real-
time PCR with primers speciﬁc for the MMP-1, -2, -3, -9, -13 and
-14 genes. MMP-1 and -13 protein production was determined
by speciﬁc ELISAs.
Results: Mass spectrometry data revealed the presence of the
Hsp90 protein in the L-OA gel shift complex. siRNA experiments
on L-OA chondrocytes showed that p130cas and Hsp90 silenc-
ing signiﬁcantly increased the expression of MMP-13 (3.5 fold;
p<0.0001, and 1.8 fold; p<0.05, respectively) and, to a lesser ex-
tent, MMP-1 (2.2 fold; p<0.0001, and 1.6 fold; p<0.05), whereas
NMP4 showed no effect. These results point to an in vivo in-
hibitory role of p130cas and Hsp90 on these MMPs. The expres-
sion of MMP-2, -3, -9 and -14 was not affected by either factor.
Interestingly, the double silencing Hsp90/p130cas produced an
additive effect on MMP-13 expression (4.9 fold; p<0.0001), while
the effect on MMP-1 was minimal (2.3 fold; p<0.005). MMP-13
and MMP-1 protein levels are reminiscent of the expression pat-
tern. The presence of IL-1β with the p130cas-silenced cells, and
to some extent with the Hsp90-silenced cells, further stimulated
MMP-13 expression, suggesting that in vivo the presence of
these factors prevents a maximal stimulation by IL-1β.
Conclusions: This study identiﬁes the intracellular proteins
p130cas and Hsp90 as inhibitors of MMP-13 expression in L-
OA chondrocytes, and demonstrates the complexity of MMP-13
regulation. Studies are underway to determine if p130cas and
Hsp90 act independently or in cooperation.
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Purpose: Determine if resistin is present in the joint following
joint injury and in primary osteoarthritis (OA) and to elucidate the
role of resistin in cartilage inﬂammation and degradation in vitro.
Abstract 153 – Figure 1
Methods: The level of resistin was measured in paired synovial
ﬂuid and serum samples from patients following joint injury (ACL
or meniscus tear), primary OA, and non-injury/non-OA controls
using adipokine multiplex kits. Localization of resistin in joint tis-
sues was visualized by immunohistochemistry (IHC) in synovial
tissue and cartilage from OA, rheumatoid arthritis (RA), and
normal controls. Murine cartilage explants were treated with re-
combinant resistin for three days in culture. Release of cytokines
was assayed in the supernatants using a cytokine multiplex kit.
Inﬂammatory marker, PGE2, was measured in culture super-
natants by ELISA. Matrix degradation was visualized in Toluidine
Blue stained cartilage sections and quantiﬁed by measuring re-
lease of sulfated GAG (sGAG) to the culture media using the
dimethylmethylene blue (DMMB) dye assay.
Results: Resistin was detected in synovial ﬂuid and serum
samples immediately after joint meniscus and ligament injury and
in the early stage of OA. The level of resistin in both synovial ﬂuid
and serum declined with increasing time after injury from 3000
pg/ml to 900 pg/ml in synovial ﬂuid and 8550 pg/ml to 5200 pg/ml
in serum. Resistin protein was detected by IHC in macrophages
and mast cells in synovial tissue from both OA and RA patients.
Cartilage was negative for resistin staining in 3/3 OA and 2/3
RA samples. Cartilage explants treated in vitro with resistin at
10 µg/ml released increased levels of MCP-1, KC (functional
homolog of human IL-8), IL-6, and PGE2 compared to untreated
control cultures (Fig. 1). Resistin stimulated degradation and
release of sGAG from the cartilage extracellular matrix.
Conclusions: Resistin is present in the joint following injury and
in primary OA and causes the release of inﬂammatory markers
and cartilage matrix degradation in vitro. Inhibition of resistin in a
diseased joint has the potential to prevent joint inﬂammation and
cartilage degradation.
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